KLK

Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting

Retrieved on: 
Vendredi, mai 10, 2024

The data in the two oral presentations today showcase the preclinical development of ATR-12 and the clinical study design of a Phase 1b study in Netherton syndrome patients.

Key Points: 
  • The data in the two oral presentations today showcase the preclinical development of ATR-12 and the clinical study design of a Phase 1b study in Netherton syndrome patients.
  • Additionally, in human ex vivo Netherton syndrome models, ATR-12 supernatant reduces protease activity nearly 7-fold to levels comparable to healthy skin.
  • The oral presentation entitled “Staphylococcus epidermidis Strain Expressing LEKTI-D6 (ATR-12) for Netherton Syndrome” also provides the study design for an active clinical trial of ATR-12 in Netherton syndrome patients.
  • “These data show the robust preclinical activity of ATR-12 in Netherton syndrome models and further supports the rationale behind our Phase 1b clinical trial in Netherton syndrome patients.”

Radiopharm Theranostics Expands Supply Agreement With TerThera for Terbium-161 Isotope Use in Prostate Cancer

Retrieved on: 
Jeudi, août 24, 2023

KLK3 is highly expressed in prostate cancer cells but has limited expression in healthy tissue.

Key Points: 
  • KLK3 is highly expressed in prostate cancer cells but has limited expression in healthy tissue.
  • Radiopharm will initiate a Phase I dose escalating trial evaluating the safety and efficacy of RAD 402 in patients with advanced prostate cancer, during the second half of 2024.
  • “We are excited about bringing this highly differentiated technology (Tb161-RAD402) to patients with advanced prostate cancer.
  • This novel radiopharmaceutical has the potential to become the first KLK-based theranostic option for individuals with advanced prostate cancer.

Palm Oil Market anticipated to Expand, says Beroe

Retrieved on: 
Mercredi, février 1, 2023

Also, the global palm oil prices and supply are highly impacted by Indonesia's palm oil trade policy, which has been dynamic in the past months.

Key Points: 
  • Also, the global palm oil prices and supply are highly impacted by Indonesia's palm oil trade policy, which has been dynamic in the past months.
  • Indonesia is one of the key palm oil-producing countries, with 59 percent of the global palm oil market, followed by Malaysia at 43 percent.
  • Most of the palm oil suppliers are integrated from the palm plantation until the end of refined palm and palm derivatives.
  • The market is anticipated to expand in the future as a result of the Malaysian government's promotion of Malaysian sustainable palm oil.

Palm Oil Market anticipated to Expand, says Beroe

Retrieved on: 
Mercredi, février 1, 2023

Also, the global palm oil prices and supply are highly impacted by Indonesia's palm oil trade policy, which has been dynamic in the past months.

Key Points: 
  • Also, the global palm oil prices and supply are highly impacted by Indonesia's palm oil trade policy, which has been dynamic in the past months.
  • Indonesia is one of the key palm oil-producing countries, with 59 percent of the global palm oil market, followed by Malaysia at 43 percent.
  • Most of the palm oil suppliers are integrated from the palm plantation until the end of refined palm and palm derivatives.
  • The market is anticipated to expand in the future as a result of the Malaysian government's promotion of Malaysian sustainable palm oil.